4164 Stock Overview
Engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
CHC Healthcare Group Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$57.00 |
| 52 Week High | NT$62.60 |
| 52 Week Low | NT$39.20 |
| Beta | 0.46 |
| 1 Month Change | 28.23% |
| 3 Month Change | 42.86% |
| 1 Year Change | -5.94% |
| 3 Year Change | 45.41% |
| 5 Year Change | 57.46% |
| Change since IPO | -37.70% |
Recent News & Updates
CHC Healthcare Group (TWSE:4164) Looks Just Right With A 33% Price Jump
Feb 14
A Look At The Intrinsic Value Of CHC Healthcare Group (TWSE:4164)
Feb 05Recent updates
CHC Healthcare Group (TWSE:4164) Looks Just Right With A 33% Price Jump
Feb 14A Look At The Intrinsic Value Of CHC Healthcare Group (TWSE:4164)
Feb 05CHC Healthcare Group (TWSE:4164) Will Pay A Larger Dividend Than Last Year At NT$2
Jun 29CHC Healthcare Group's (TWSE:4164) Dividend Will Be Increased To NT$2.01
Jun 15If You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%
Mar 08CHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 07
Should CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?
Jan 21Is CHC Healthcare Group (TPE:4164) Likely To Turn Things Around?
Jan 06Is CHC Healthcare Group (TPE:4164) Using Too Much Debt?
Dec 22CHC Healthcare Group (TPE:4164) Share Prices Have Dropped 32% In The Last Five Years
Dec 07Are CHC Healthcare Group's (TPE:4164) Statutory Earnings A Good Guide To Its Underlying Profitability?
Nov 22Shareholder Returns
| 4164 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | 1.2% | 0.7% | 2.6% |
| 1Y | -5.9% | -9.5% | 23.3% |
Return vs Industry: 4164 exceeded the TW Healthcare industry which returned -10.5% over the past year.
Return vs Market: 4164 underperformed the TW Market which returned 22.3% over the past year.
Price Volatility
| 4164 volatility | |
|---|---|
| 4164 Average Weekly Movement | 4.6% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.9% |
| 10% least volatile stocks in TW Market | 2.0% |
Stable Share Price: 4164 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4164's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | n/a | Ming-Lun Lee | www.chcg.com |
CHC Healthcare Group, together with its subsidiaries, engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. The company is also involved in the sale, leasing, installing, and repairing of medical instruments. In addition, it engages in the sale of ophthalmic equipment; irradiation business; sale of drug and health supplements; consulting, elderly residence, and senior fitness services; Long-term care services; and leasing of veterinary medical instruments.
CHC Healthcare Group Fundamentals Summary
| 4164 fundamental statistics | |
|---|---|
| Market cap | NT$9.51b |
| Earnings (TTM) | NT$324.06m |
| Revenue (TTM) | NT$4.03b |
29.4x
P/E Ratio2.4x
P/S RatioIs 4164 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4164 income statement (TTM) | |
|---|---|
| Revenue | NT$4.03b |
| Cost of Revenue | NT$3.09b |
| Gross Profit | NT$938.13m |
| Other Expenses | NT$614.08m |
| Earnings | NT$324.06m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.94 |
| Gross Margin | 23.27% |
| Net Profit Margin | 8.04% |
| Debt/Equity Ratio | 80.0% |
How did 4164 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield103%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 03:28 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CHC Healthcare Group is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Joseph Quinn | Macquarie Research |
| Xiaowei Huang | Masterlink Securities Corp. |